Also trades as: IDHC.L (LSE) · $vol 0M
IDGXF OTC
Integrated Diagnostics Holdings plc
1W: -4.0%
1M: -4.0%
3M: +7.0%
YTD: -22.1%
1Y: +11.2%
3Y: -39.6%
$0.53
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$5.7B
+38.7% ▲
5Y CAGR: +20.8%
Gross Profit
$2.2B
+43.1% ▲
5Y CAGR: +15.0%
Operating Income
$1.2B
+64.6% ▲
5Y CAGR: +9.0%
Net Income
$1.1B
+111.1% ▲
5Y CAGR: +16.1%
EPS (Diluted)
$1.82
+114.1% ▲
5Y CAGR: +16.4%
EBITDA
$2.1B
+63.5% ▲
5Y CAGR: +16.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2.7B | $5.2B | $3.6B | $4.1B | $5.7B |
| YoY Growth | +19.3% | +96.7% | -31.0% | +14.4% | +38.7% |
| Cost of Revenue | $1.3B | $2.4B | $2.1B | $2.6B | $3.5B |
| Gross Profit | $1.3B | $2.8B | $1.5B | $1.5B | $2.2B |
| Gross Margin | 50.5% | 53.7% | 40.6% | 37.0% | 38.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $329M | $317M | $359M | $401M | $533M |
| Operating Expenses | $357M | $542M | $630M | $787M | $967M |
| Operating Income | $986M | $2.3B | $832M | $738M | $1.2B |
| Operating Margin | 37.1% | 43.3% | 23.1% | 17.9% | 21.2% |
| Interest Expense | $68M | $98M | $123M | $142M | $171M |
| Income Before Tax | $969M | $2.2B | $854M | $737M | $1.4B |
| Tax Expense | $360M | $740M | $327M | $269M | $431M |
| Net Income | $594M | $1.4B | $541M | $510M | $1.1B |
| Net Margin | 22.4% | 27.0% | 15.0% | 12.4% | 18.8% |
| EPS (Diluted) | $0.99 | $2.35 | $0.90 | $0.85 | $1.82 |
| EBITDA | $1.2B | $2.6B | $1.3B | $1.3B | $2.1B |
| Shares Outstanding | 600M | 600M | 600M | 600M | 594M |